Relieving occupational fatigue by consumption of a beverage containing γ-amino butyric acid

Journal of Nutritional Science and Vitaminology

Volumn 57, Issue 1, 2011, Pages 9-15

  Kanehira, Tsutomu ^a   Nakamura, Yoshiko ^a   Nakamura, Kenji ^b   Horie, Kenji ^b   Horie, Noriko ^b   Furugori, Kaori ^c   Sauchi, Yusuke ^b   Yokogoshi, Hidehiko ^c  

^a Health Functional Research   (Japan)

^b Pharma Foods International Co Ltd   (Japan)

^c UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Chromogranin A; Concentration; Cortisol; GABA; Psychological fatigue

Indexed keywords

4 AMINOBUTYRIC ACID; CHROMOGRANIN A; HYDROCORTISONE;

ADULT; ANGER; ANXIETY; ARTICLE; BEVERAGE; CLINICAL ARTICLE; CONFUSION; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC TEST; FATIGUE; FEMALE; FOOD INTAKE; HOSTILITY; HUMAN; JAPANESE; MALE; MOOD CHANGE; OCCUPATIONAL DISEASE; PROFILE OF MOOD STATES; SALIVA LEVEL; SALIVATION; TENSION; UCHIDA KRAEPELIN PSYCHODIAGNOSTIC TEST; VISUAL ANALOG SCALE;

ADULT; BEVERAGES; CHROMOGRANIN A; CHRONIC DISEASE; FATIGUE; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; HYDROCORTISONE; MALE; PAIN MEASUREMENT; PSYCHOLOGICAL TESTS; QUESTIONNAIRES; YOUNG ADULT;

UCHIDA;

EID: 79955551061     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.57.9     Document Type: Article

References (45)

1. Kuratsune H. 2007. Overview of chronic fatigue syndrome focusing on prevalence and diagnostic criteria. Nippon Rinsho 65: 983-990.
2. Roberts E, Frankel S. 1950. γ-Aminobutyric acid in brain: its formation from glutamic acid. J Biol Chem 187: 55-63.
3. Erdo SL. 1985. Peripheral GABA ergic mechanisms. Trends Pharmacol Sci 6: 205-208.
4. Kim HY, Yokozawa T, Nakagawa T, Sasaki S. 2004. Protective effect of γ -aminobutyric acid against glycerolinduced acute renal failure in rats. Food Chem Toxocol 42: 2009-2014.
5. Curtis DR, Lacey G. 1994. GABA-B receptor-mediated spinal inhibition. Neuroreport 5: 540-542.
6. Olney JW. 1990. Excitotoxic amino acids and neuropsychiatric disorders. Annu Rev Pharmacol Toxicol 30: 47-71.
7. Shizuka F, Kido Y, Nakazawa T, Kitajima H, Aizawa C, Kayamura H, Ichijo N. 2004. Antihypertensive effect of γ-amino butyric acid enriched soy products in spontaneously hypertensive rats. Biofactors 22: 165-167.
8. Gordon FJ, Sved AF. 2002. Neurotransmitters in central cardiovascular regulations: Glutamate and GABA. Clin Exp Pharmacol Physiol 29: 522-524.
9. Gozlinska B, Czyzewska-Szafran H, Plaznik A. 1999. Blood pressure and hypothalamic NA-GABA interaction in spontaneously hypertensive rats (SHR): effect of administration DSP-4. Acta Pol Pharm 56: 245-248.
10. Zhang J, Mifflin SW. 1998. Receptor subtype specific effects of GABA agonists on neurons receiving aortic depressor nerve inputs within the nucleus of the solitary tract. J Auton Nerv Syst 73: 170-181.
11. Hu JH, He XB, Wu Q, Yan YC, Koide SS. 2002. Biphasic effect of GABA on rat sperm acrosome reaction: involvement of GABAA and GABAB receptors. Arch Androl 48: 369-378.
12. Minuk GY. 2000. GABA and hepatocellular carcinoma. Mol Cell Biochem 207: 105-108.
13. Abdou AM, Higashiguchi S, Horie K, Kim M, Hatta H, Yokogoshi H. 2006. Relaxation and immunity enhancement effects of γ-Aminobutyric acid (GABA) administration in humans. Biofactors 26: 201-208.
14. Toda M, Den R, Nagasawa S, Kitamura K, Morimoto K. 2005. Relationship between lifestyle scores and salivary stress markers cortisol and chromogranin A. Arch Environ Occup Health 60: 266-269.
15. Kirschbaum C, Hellhammer DH. 1989. Salivary cortisol in psychobiological research: an overview. Neuropsychobiology 22: 150-169.
16. Stahl F, Dörner G. 1982. Responses of salivary cortisol levels to stress-situations. Endocrinology 80: 158-162.
17. Hellhammer DH, Heib C, Hubert W, Rolf L. 1985. Relationships between salivary cortisol release and behavioral coping under examination stress. IRCS J Med Sci 13: 1179-1180.
18. Jones KV, Copolov DL, Outch KH. 1986. Type A, test performance and salivary cortisol. J Psychosom Res 30: 699-707.
19. Martinek L, Oberascher-Holzinger K, Weishuhn S, Klimesch W, Kerschbaum HH. 2003. Anticipated academic examinations induce distinct cortisol responses in adolescent pupils. Neuro Endocrinol Lett 24: 449-453.
20. Ben-Aryeh H, Roll R, Kahana L, Malberger E, Szargel R, Gutman D. 1985. Saliva as an indicator of stress. Int J Psychosom 32: 3-8.
21. Smith AD, Winkler H. 1967. Purification and properties of an acidic protein from chromaffin granules of bovine adrenal medulla. Biochem J 103: 483-492.
22. Smith WJ, Kirshner N. 1967. A specific soluble protein from the catecholamine storage vesicles of bovine adrenal medulla. Mol Pharmacol 3: 52-62.
23. Schneider FH, Smith AD, Winkler H. 1967. Secretion from the adrenal medulla: biochemical evidence for exocytosis. Br J Pharmacol Chemother 31: 94-104.
24. Blascko H, Comiline RS, Schneider FH, Silver M, Smith AD. 1967. Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation. Nature 215: 58-59.
25. De Potter W, Smith AD, De Shaepdryver AF. 1970. Subcellular fractionation of splenic nerve: ATP, chromogranin A, and dopamine-_-hydroxylase in noradrenergic vesicles. Tissue Cell 2: 529-546.
26. Smith AD, De Potter WP, Moerman EJ, De Shaepdryver AF. 1970. Release of dopamine-β-hydroxylase and chromogranin A upon stimulation of the sympathetic nerve. Tissue Cell 2: 547-568.
27. O'Connor DT. 1983. Chromogranin: widespread immuno-reactivity in polypeptide hormone producing tissues and in serum. Regul Pept 6: 263-280.
28. Saruta J, Tsukinoki K, Sasaguri K, Ishii H, Yasuda M, Osamura YR, Watanabe Y, Sato S. 2005. Expression and localization of chromogranin A gene and protein in human submandibular gland. Cells Tissues Organs 180: 237-244.
29. Toda M, Morimoto K, Nagasawa S, Kitamura K. 2006. Change in salivary physiological stress markers by spa bathing. Biomed Res 27: 11-14.
30. Toda M, Kusakabe S, Nagasawa S, Kitamura K, Morimoto K. 2007. Effect of laughter on salivary endocrinological stress marker chromogranin A. Biomed Res 28: 115-118.
31. Smriga M, Ando T, Akutsu M, Furukawa Y, Miwa K, Morinaga Y. 2007. Oral treatment with L-lysine and Larginine reduces anxiety and basal cortisol levels in healthy humans. Biomed Res 28: 85-90.
32. Okada T, Sugishita T, Murakami T, Murai H, Saikusa T, Horino T, Onoda A, Kajimoto O, Takahashi R, Takahashi T. 2000. Effect of the defatted rice germ enriched with GABA for sleeplessness, depression, autonomic disorder by oral administration. Nippon Shokuhin Kagaku Kogaku Kaishi 47: 596-603 (in Japanese with English summary).
33. Fujibayashi M, Kamiya T, Takagaki K, Moritani T. 2008. Activation autonomic nervous system activity by the oral ingestion of GABA. J Jpn Soc Nutr Food Sci 61: 129-133 (in Japanese with English summary).
34. Tujioka K, Okuyama S, Yokogoshi H, Fukaya Y, Hayase K, Horie K, Kim M. 2007. Dietary _-aminobutyric acid affects the brain protein synthesis rate in young rats. Amino Acids 32: 255-260.
35. Freyd M. 1923. The graphic rating scale. J Educ Psychol 14: 83-102.
36. Working Group for Occupational Fatigue. 1970. Suggested "new subjective symptom examination". Sangyo Igaku 12: 196-197 (in Japanese).
37. Shimbo M, Kuroiwa C, Yokogoshi H. 2004. The effects of carbohydrate consumption on stress levels in humans. J Nutr Sci Vitaminol 50: 283-285.
38. Kuraishi S, Kato M, Tsujioka B. 2000. Development of the "Uchida-Kuraepelin Psychodiagnostic Test" in Japan. Psychologia 1: 104-109.
39. Yokogoshi H. 2007. Stress and GABA. Shizuoka Shimbun, Shizuoka.
40. Gerner RH, Hare TA. 1981. CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa. Am J Psychiatry 138: 1098-1101.
41. Gold BI, Bowers MB Jr, Roth RH, Sweeney DW. 1980. GABA levels in CSF of patients with psychiatric disorders. Am J Psychiatry 137: 362-364.
42. Kasa K, Otsuki S, Yamamoto M, Sato M, Kuroda H, Ogawa N. 1982. Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders. Biol Psychiatry 17: 877-883.
43. Petty F, Schlesser MA. 1981. Plasma GABA in affective illness. A preliminary investigation. J Affect Disord 3: 339-343.
44. Abdou AM, Higashiguchi S, Horie K, Kim M, Hatta H, Yokogoshi H. 2006. Relaxation and immunity enhancement effects of _-aminobutyric acid (GABA) administration in humans. BioFactors 26: 201-208.
45. Shibata T. 1967. Experimental study on the cerebral ciculation and metabolism in brain injury in the acute stage-with reference to substances relating to cell metabolism. No To Shinkei 19: 231-240 (in Japanese).